News | Endovascular Aortic Repair | July 08, 2016

Michigan Hospital Employing Conscious Sedation for Aortic Aneurysm Repair

Beaumont Hospital-Royal Oak believed to be the first facility in the state to eliminate general anesthesia for minimally invasive repair

Beaumont Hospital, Michigan, endovascular aortic repair, EVAR, conscious sedation

July 8, 2016 — Kirk Schoenherr, 56, of Clinton Township, Mich., recently became just the second patient at Beaumont Hospital, Royal Oak, to receive conscious sedation for thoracic aortic aneurism repair. Conscious sedation employs a combination of medicines that block pain and allow patients to relax and remain awake during a medical procedure.

 

Read the article "Moderate Sedation Shows Promise for TAVR Patients" 

 

Though many hospitals offer minimally invasive repair of the descending thoracic aorta, it is believed that Beaumont Hospital, Royal Oak, is the only one in the state to combine it with conscious sedation.

Not having to go under general anesthesia was a big relief,” said Schoenherr. “I was more alert afterwards and able to enjoy a greater feeling of awareness, contributing to less anxiety. Being intubated scratches your throat and is painful. And once the tube is out, it’s harder to breath.

“Most importantly, since I wasn’t intubated, I could immediately return to my regular diet,” Schoenherr said.

Schoenherr began experiencing pain related to his aortic ulcer this past Easter. He was at risk for a rupture, which often occurs without warning and leads to sudden death. The problem was diagnosed by emergency center staff at Beaumont Hospital, Troy, and surgically repaired June 1 at Royal Oak.

This multidisciplinary approach to aortic repair combines the expertise of Beaumont’s chief of vascular surgery, O. William Brown, M.D., and cardiac surgeons Alessandro Vivacqua, M.D., and Jeffrey Altshuler, M.D.

 “Conscious sedation eliminates the risks of general anesthesia,” Vivacqua said. “The patient doesn’t have to be intubated or placed on a ventilator. There are no concerns regarding decrease in blood pressure or heart rate. Conscious sedation is safe and much more comfortable.”

Additionally, because the patient is awake during the procedure, the surgical team is able to closely monitor, diagnose and treat possible spinal cord complications, Brown said.

“Beaumont is at the forefront of reducing overall surgical risk and is constantly working to make procedures less invasive,” Brown said.

For more information: www.beaumont.org

 

Related Content for Conscious Sedadtion and TAVR:

VIDEO: Conscious Sedation for TAVR Procedures

VIDEO: The State of TAVR in 2016

Conscious Sedation TAVR Reduced Length-of-Stay and Hospital Costs

Moderate Sedation Shows Promise for TAVR Patients

UTHealth, Memorial Hermann Perform Conscious Sedation TAVR Procedure

Related Content

Nuance Communications Inc. introduced Nuance Cardiovascular CAPD, a new computer-assisted physician documentation (CAPD) solution designed to help cardiologists improve the quality of complex documentation and the accuracy of reimbursement for cardiac catheterization procedures. The Nuance Cardiovascular CAPD solution is available through a partnership with ZHealth for this solution, which is based on patented algorithms built with ZHealth’s interventional documentation and coding expertise.
News | Cath Lab | January 31, 2020
January 29, 2020 – Nuance Communications Inc.
Videos | Cath Lab | January 09, 2020
Haval Chweich, M.D., medical director of the cardiac critical care unit (CCU) at Tufts Medical Center, and assistant...
People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.  In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS) withdrew their support for European practice guidelines that endorse the use of coronary stents in many patients with left main coronary artery disease.

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.

News | Cath Lab | January 02, 2020 | Dave Fornell, Editor
January 2, 2020 — In early December 2019, leaders of the European As...
News | Cath Lab | December 18, 2019
December 18, 2019 — Cook Medical initiated a recall of its CrossCath Support Catheters in November, which the U.S.
Gallery | Cath Lab | October 31, 2019 | Dave Fornell, Editor
This is a photo essay of the interventional cardiology and structural heart technologies on the expo floor and discus
The Alphenix Aero Package from Canon Medical Systems USA, Inc. enables OBLs and ASCs to attain premium technology at a flexible price point by tailoring Canon Medical’s Alphenix systems to fit their facilities’ needs.

The Alphenix Aero Package from Canon Medical Systems USA, Inc. enables OBLs and ASCs to attain premium technology at a flexible price point by tailoring Canon Medical’s Alphenix systems to fit their facilities’ needs.

Technology | Cath Lab | October 28, 2019
Office based labs (OBLs) and ambulatory surgery centers (ASCs) require a fresh perspective from imaging vendors.
Marco Costa, M.D., Ph.D., MBA, president, UH Harrington Heart and Vascular Institute, performing a cath lab procedure.

Marco Costa, M.D., Ph.D., MBA, president, UH Harrington Heart and Vascular Institute, performing a cath lab procedure.

News | Cath Lab | October 28, 2019
October 28, 2019 — Leaders within University Hospitals and the Harrington Heart and Vascular Institute had a vision t
OmniVision Announces Guinness World Record for Smallest Image Sensor

OmniVision's OVM6948 CameraCubeChip, a fully packaged, wafer-level camera module measuring 0.65mm x 0.65mm x 1.158mm, built on OmniVision's OV6948, winner of the Guinness World Record for “The Smallest Image Sensor Commercially Available.”

News | Cath Lab | October 22, 2019
October 22, 2019 — OmniVision Technologies Inc.
People watch the presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., live in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long term surgical outcomes. #TCT2019

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes. 

Feature | Cath Lab | October 03, 2019
October 3, 2019 – Five-year data from the EXCEL Trial showed patients with left main coronary disease treated with pe
Overlay Init